Rituximab in antibody-mediated rejection following kidney transplantation: clinical and pathological outcomes

Authors

Institutions

Publication Details

Journal
BMC Nephrology
Published
2025-10-29
DOI
https://doi.org/10.1186/s12882-025-04543-z
Citations
1
Primary Topic
Renal Transplantation Outcomes and Treatments
Type
article
Field-Weighted Citation Impact
1.99
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Rituximab in antibody-mediated rejection following kidney transplantation: clinical and pathological outcomes

Banu Kadıoğlu Yılmaz, Raika Durusoy, Gökalp Okut, Adam Uslu et al.
1 citations
BMC Nephrology
Renal Transplantation Outcomes and Treatments
1.99
article

Rituximab in antibody-mediated rejection following kidney transplantation: clinical and pathological outcomes

Banu Kadıoğlu Yılmaz, Raika Durusoy, Gökalp Okut, Adam Uslu, Murat Doğan, Funda Taşlı, Mustafa Uğur, Emine Kocabaş
article en
1 citations

Abstract

No abstract available for this paper.
BMC NephrologyVol. 26(1)
Izmir University (TR), Ege University (TR)
Openalex Percentile: Top 11%
Renal Transplantation Outcomes and Treatments
1.99
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.